Corpus Intelligence IC Memo — ASHLAND COMMUNITY HOSPITAL 2026-04-26 05:29 UTC
IC Memo — ASHLAND COMMUNITY HOSPITAL
Investment Committee Memorandum | OR | 36 beds | Grade C | EBITDA uplift $5.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ASHLAND COMMUNITY HOSPITAL

CCN 380005 | JACKSON, OR | 36 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ASHLAND COMMUNITY HOSPITAL is a 36-bed safety-net/medicaid heavy in JACKSON, OR with $74.8M in net patient revenue and a -5.3% operating margin. The hospital serves a payer mix of 33.5% Medicare, 38.7% Medicaid, and 27.8% commercial.

Thesis: Turnaround. Our ML models identify $5.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.3% to 2.0% (+736bps).

Net Revenue HCRIS$74.8M
Current EBITDA COMPUTED$-4.0M
Operating Margin COMPUTED-5.3%
Occupancy HCRIS62.8%
Revenue / Bed COMPUTED$2.1M
Net-to-Gross HCRIS34.9%
Distress Probability ML53.1%

2. Market Context & Competitive Position

63
OR Hospitals
-8.1%
State Median Margin
27
Comparable Hospitals

OR has 63 Medicare-certified hospitals with a median operating margin of -8.1%. The target's margin of -5.3% places it above the state median. Among 27 size-comparable peers (18-72 beds), the median margin is -6.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-72), prioritizing same-state peers. 27 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ASHLAND COMMUNITY HOSPITAL (Target)OR36$74.8M-5.3%
SAMARITAN ALBANY GENERAL HOSPIOR67$220.1M-12.0%
GOOD SHEPHERD MEDICAL CENTEROR25$177.5M5.3%
COLUMBIA MEMORIAL HOSPITALOR25$165.9M5.2%
SAMARITAN LEBANON COMM HOSPITAOR25$157.9M3.9%
PROVIDENCE NEWBERG MEDICAL CENOR40$151.5M10.0%
SAMARITAN PACIFIC COMM HOSPITAOR25$141.7M3.7%
GRANDE RONDE HOSPITALOR25$134.8M-4.1%
PROVIDENCE MILWAUKIE HOSPITALOR40$128.8M-9.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.6M+210bp18mo
Cost to Collect4.5%2.5%$1.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$910K+122bp9mo
Clean Claim Rate88.0%96.0%$48K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.6M
Cost to Collect
$1.5M
Denial Rate Reduction
$1.5M
A/R Days Reduction
$910K
Clean Claim Rate
$48K
Total EBITDA Uplift$5.5M
Current EBITDA$-4.0M
+ RCM Uplift+$5.5M
Pro Forma EBITDA$1.5M
Current Margin-5.3%
Pro Forma Margin2.0%
WC Released (1x)$2.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-6.2M$28.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-6.2M$29.5M0.00x-100.0%
Bull Case9.0x11.0x$-5.5M$45.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-5.5M$48.2M0.00x-100.0%
Bear Case11.0x10.0x$-6.8M$3.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-6.8M$1.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (38.7%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 53.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 27 hospitals with 18-72 beds
  • Same-state prioritization (n=28)
  • Comp margins: P25=-15.0% / P50=-6.1% / P75=3.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.